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osting by EAbstract The present study was designed to evaluate the relationship between serum leptin levels
and the hormones related to fertility in Iraqi females with polycystic ovary syndrome (PCOS)
and marital status. This study was conducted during the period from July to December 2007.
Twenty-four women (12 married and 12 unmarried) with PCOS and not maintained on any type
of therapy were included in the study. Twelve healthy and normal ovulatory women with an age
range matched with that of PCOS women were included. After an overnight fasting, blood samples
were drawn from all women at random days. While in those with regular menstrual cycles, blood
samples were obtained during the follicular phase of the cycle, except for samples utilized for the
assay of progesterone that performed in the day 21 of the cycle (luteal phase). After preparation
of serum, the levels of leptin, luteinizing hormone (LH), follicle-stimulation hormone (FSH), pro-
gesterone, testosterone and prolactin were analyzed. Both groups of PCOS patients showed signif-
icantly lower levels of serum leptin, while prolactin, LH and FSH and testosterone were
signiﬁcantly elevated compared to controls. No signiﬁcant differences were reported among PCOS
patients with different marital status. In conclusion, impaired plasma leptin levels in PCOS women
were associated with impaired endocrinological parameters related to fertility.
ª 2009 King Saud University. All rights reserved.ity. All rights reserved. Peer-
d University.
lsevier1. Introduction
Leptin is a signaling peptide produced in fat cells, which
suppresses neuroendocrine adaptations to altered nutritional
status (Bergendahl et al., 1999; Karlsson et al., 1998). Leptin
secretion ismodulated by total fat cell mass, sex steroids, growth
hormone, glucocorticoids, insulin, and sympathetic activity
(Heiman et al., 1997; Shimizu et al., 1997). Animal studies
suggest that the absence of leptin results in obesity and in fertility
(Barash et al., 1996). Human studies also support the evidence
that leptin plays signiﬁcant role in reproductive biology;
42 B.H. Khalafﬂuctuation of leptin during menstrual cycle (Messinis et al.,
1998), high leptin level in pre-menopausal, and leptin involve-
ment in gender-related differences in insulin sensitivity all sup-
port this role (Shimizu et al., 1997; Fernandez-Real et al., 1998).
Polycystic ovary syndrome (PCOS) as a common endocrine
disorder is associated with obesity, hyperinsulinism, insulin
resistance and hyperandrogenism (Ovalle and Azziz, 2002;
Acien et al., 1999). PCOS and its association with leptin have
also been studied (Lindheim et al., 2000; Carmina et al., 1999).
Some studies suggest that elevated leptin levels may cause fol-
licular arrest (Agarawal et al., 1997), while others have not
found any difference between serum leptin level of PCOS wo-
men and those of controls (Mantoros et al., 1997). It has been
found that below certain body mass index (BMI), hyper-
androgenic women with PCOS have lower leptin levels than
controls. On the other hand, overweight and obese PCOS sub-
jects produce insufﬁcient leptin for a given fat mass, relative to
the degree of hyperinsulinemia, potentially because of the com-
peting effects of adipocyte insulin resistance and androgens on
leptin (Remsberg et al., 2002). PCOS endocrinopathy is also
associated with obesity, and can be both the result of a combi-
nation of genetic and environmental factors (Sanders, 2002).
The present study was designed to evaluate the relationship be-
tween leptin levels and hormones related to fertility in married
and unmarried women with PCOS.
2. Subjects and methods
Twenty-four women (12 married and 12 unmarried with age
range 26.6 ± 4.8 years; body mass index of 30.9 ± 1.6 and
29.9 ± 1.3 respectively, and C-peptide level of 6.7 ± 0.8
ng/ml and 6.9 ± 0.6 ng/ml, respectively) with PCOS not main-
tained on any type of therapy were included in the study. The
diagnosis of PCOS was based on the classic criteria of hyper-
androgenism and chronic anovulation (Zawadaki and Dunaif,
1992). Twelve (6 married and 6 unmarried) healthy and normal
ovulatory women with an age range (23.5 ± 3.9 years)
matched with that of PCOS women were included and C-pep-
tide level of 4.05 ± 0.28 ng/ml. The normal women were
selected on the bases of not having hirsutism or signs and
symptoms of androgenization, and all had normal ovulatory
menstrual cycles. The study was conducted in the Specialized
Center for Diabetes and Endocrinology, Al-Rusafa, Baghdad,
during the period from July to December 2007, and the study
protocol was approved by the Committee for Medical Ethics
there, and consent was signed by all participants. Subjects
who were on contraceptive pills or any other hormonal medi-
cations, those who were breastfeeding their babies were ex-
cluded from the study.
After an overnight fasting, blood samples were drawn from
PCOS women at random days. While in those with regularTable 1 Leptin, prolactin, LH and FSH in married and unmarried
females.
Groups Serum leptin (ng/ml) Serum prolac
Healthy females 7.2 ± 0.4a 10.0 ± 1.1a
Unmarried PCO patients 5.5 ± 0.5b 20.1 ± 2.4b
Married PCO patients 4.7 ± 0.5b 30.9 ± 2.1c
Values are presented as mean ± SEM; n= 12; values with non-identical s
considered signiﬁcantly different (P< 0.05).menstrual cycles, blood samples were obtained during the fol-
licular phase of the cycle, except for samples utilized for the as-
say of progesterone that performed in the day 21 of the cycle
(luteal phase). After preparation of serum, the levels of leptin
(Guillaume and Bjorntrop, 1996), LH (Knobil, 1980), FSH
(Uotila et al., 1981), progesterone, testosterone and prolactin
(Tietz, 1995) were analyzed by (ELIZA) according to standard
procedures. All results were expressed as mean ± SEM. Anal-
ysis of variance (ANOVA) was used for comparison. Post hoc
testing was carried by Student’s t-test with log transformation.
P< 0.05 was considered statistically signiﬁcant.
3. Results
In Table 1, both groups of PCOS patients showed signiﬁcantly
lower levels of serum leptin compared to healthy females
(23.0% and 35%, respectively); although no signiﬁcant differ-
ence in leptin levels existed between both patients groups. Both
unmarried and married females with PCOS showed signiﬁ-
cantly higher prolactin levels in their serum compared to
healthy comparators (100% and 209%, respectively), and mar-
ried PCOS patients are presented with signiﬁcantly higher ser-
um levels compared to unmarried group (54%). Serum LH
levels were signiﬁcantly elevated in unmarried and married
groups (119% and 186%, respectively) compared to healthy
females and no signiﬁcant difference was reported between
both groups of PCOS patients in this respect. Meanwhile,
serum FSH levels were signiﬁcantly elevated in married PCOS
patients compared to unmarried patients and healthy control
groups (35% and 42%, respectively).
In Table 2, both groups of unmarried and married PCOS
patients showed elevated levels of serum testosterone which
were signiﬁcantly different compared to healthy females
(172% and 186%, respectively), and were not signiﬁcantly dif-
ferent when compared with each other. However, serum pro-
gesterone and estrogen levels did not signiﬁcantly changed in
both patients groups compared to control group.
4. Discussion
The rise in leptin levels at the onset of puberty and fall in post-
menopausal women suggested that leptin may be associated
with normal reproductive events (Lakho et al., 2001). Low lep-
tin levels may also disrupt the reproductive system as ovula-
tion stops in starving women and testosterone levels fall in
men (Vogel, 1996). Polycystic ovary syndrome (PCOS) as a
common endocrine disorder is associated with obesity, hyper-
insulinism, insulin resistance and hyperandrogenism (Ovalle
and Azziz, 2002). In this respect many studies revealed no sig-
niﬁcant difference in serum leptin levels between PCOS women
and healthy controls (Mantoros et al., 1997). In the presentfemales with polycystic ovary syndrome compared with healthy
tin (ng/ml) Serum LH (mIU/ml) Serum FSH (mIU/ml)
7.8 ± 0.5a 7.1 ± 0.4a
17.1 ± 1.3b 7.5 ± 0.7a
22.3 ± 2.5c 10.1 ± 1.2b
uperscripts (a, b, c) for the same parameter within the same group are
Table 2 Testosterone, progesterone and estrogen in married and unmarried females with polycystic ovary syndrome compared with
healthy females.
Groups Serum testosterone (ng/ml) Serum progesterone (ng/ml) Serum estrogen (pg/ml)
Healthy females 0.5 ± 0.06a 7.5 ± 0.82a 237.1 ± 24.6a
Unmarried PCOS patients 1.36 ± 0.11b 10.3 ± 1.52a 274.3 ± 29.1a
Married PCOS patients 1.43 ± 0.13b 10.1 ± 1.58a 284.0 ± 31.0a
Values are presented as mean ± SEM; n= 12; values with non-identical superscripts (a, b) for the same parameter within the same group are
considered signiﬁcantly different (P< 0.05).
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compared to control group this seem to be consistent with that
reported by Remsberg et al. (2002) which indicated that below
a certain body mass index, hyper-androgenic women with
PCOS have lower leptin levels than their matched controls.
Meanwhile, overweight and obese PCOS subjects produce
insufﬁcient leptin for a given fat mass relative to the degree
of hyperinsulinemia probably because of the competing effects
of adipocytes insulin resistance and androgens on leptin
(Remsberg et al., 2002).
The present study revealed that serum leptin levels in both
married and unmarried women with PCOS were lower than
that reported in controls; this may be attributed to the pres-
ence of insulin resistance in adipocytes, usually accompanied
with PCOS and the type of fat accumulated there. An impor-
tant component of obesity in women with PCOS is the accu-
mulation of visceral fat which secrets less leptin than
subcutaneous fat (Jacobs and Conway, 1999). This difference
may also be due to difference in the BMI of control group
from that of PCOS subjects (Laughlin and Morales, 1997).
Although many multiparous women are obese, most of them
can conceive regularly. Indeed, a large study of fertile women
did not show any relationship between roles of conception and
body weight/BMI (Howe et al., 1985). Obese and overweight
women are over represented in gynecological and reproductive
medical clinics and obesity in teenagers is more common
among married girls who never became pregnant as compared
to married women who did become pregnant (Hartz et al.,
1979). Carmina et al. (1999) demonstrated a negative correla-
tion between leptin and dehydroepiandrostenone levels in 21
lean PCOS, suggesting that androgens may play a role in sup-
pressing serum leptin (Carmina et al., 1999). Another study
showed that leptin concentrations were inversely correlated
with LH levels independent on body weight and insulin resis-
tance (Spritzer et al., 2001). In the present study, serum LH
levels were elevated in both married and unmarried PCOS wo-
men compared to controls; this result was consistent with that
reported by others (Kalra et al., 2001); though married PCOS
show higher LH levels compared to unmarried one, this may
be attributed to that androgen production by theca is LH
dependent. There are many studies described gonadotropin
abnormalities in PCOS; the mechanism underlying increased
LH has remained unclear. There is evidence that both hypo-
thalamic and pituitary mechanisms contribute to such type
of dysfunction in PCOS and increased LH pulse frequency
has been documented (Taylor et al., 1997). Moreover, the in-
creased frequency of pulsatile GnRH secretion in PCOS was
accompanied by an increase in the over all quantity of GnRH.
(Yanira et al., 2006).
Higher prevalence of hyperprolactinemia has been reported
among women with PCOS (Kovacs, 2003), and the results ofthe present study showed the same pattern of changes in prolac-
tin levels in both groups ofPCOSwomen.The cross talk between
prolactin and insulin signaling pathway in brown adipocytes
demonstrated that prolactin potentiates insulin-stimulated
secretion of leptin by brown adipose tissue (Viengchareun
et al., 2004). In PCOS patients with hyperprolactinemia other
causes must be investigated because hyperprolactinemia is not
a clinical manifestation of PCOS (Filno et al., 2007). According
to the results of the present study, both married and unmarried
PCOS women exhibited higher mean plasma prolactin levels
than healthy women, and associated with the decrease in leptin
levels; this observation is in accordance with the assumption
that, in humans, prolactin probably may play a role in modulat-
ing leptin secretion in women with PCOS. Although no litera-
tures available that explain the differences between married
and unmarried women in this respect, the changes in life style
(Crosgnani et al., 2003) and the awareness of unmarried women
about the necessity to treat the conditionmayplay a role. In con-
clusion, impaired plasma leptin levels in PCOS women were
associated with impaired endocrinological parameters related
to fertility.Acknowledgment
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